Atria Wealth Solutions, Inc. Organon & Co. Transaction History

Atria Wealth Solutions, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 14, 2023	BUY	$21.42 - $32.08 $176,265 - $263,986	8,229 New	8,229 $193,000
Q4 2022 Aug 30, 2023	BUY	$23.31 - $28.61 $191,817 - $235,431	8,229 New	8,229 $229,000
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $9,999 - $12,273	-429 Reduced 4.95%	8,229 $229,000
Q3 2022 Feb 13, 2023	SELL	$23.4 - $34.25 $200,982 - $294,173	-8,589 Reduced 49.8%	8,658 $202,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $54,662 - $80,008	2,336 Added 15.67%	17,247 $497,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $272,782 - $335,162	-8,616 Reduced 36.62%	14,911 $503,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $716,397 - $926,022	23,527 New	23,527 $821,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.